Featured Company Pitch Session
Early Stage firms seeking licensing opportunities or Seed, Angel, Series A or B funding are encouraged to secure a 15-minute presentation slot at the up and coming RESI Partnering Conference. Presenting at RESI is a unique opportunity to get in front of the early stage partners that make RESI the go-to event for companies seeking strategic partners. RESI will host over 600 global early stage investors ranging from family offices and angels to strategic Pharma and MedTech players. Presenting at RESI gives companies an opportunity to build their profile with investors and strategic partners.
- RESI registration fee per attendee (register here)
- Presentation fee per company: $1,500
Who should present?
Any life science company that is developing products in the Drugs, Devices Diagnostics or Digital Health arena and is seeking a strategic partner for licensing or investment.
- Early Stage companies are invited to request a 15-minute company presentation.
- Presenting companies will be featured in the LSN Newsletter and in the RESI conference program guide.
If your firm is interested in presenting at the Featured Early-Stage Company Pitch Session please click apply button above. You will be required to submit a two-page Executive Summary and 10-12 page pitch deck with your application.
500+ Early Stage Investors Converge on RESI San Francisco – Jan.14, 2020
RESI San Francisco has become the key venue to meet early stage investors and companies during the annual January healthcare conference week. Millions upon millions of dollars have been invested in early stage companies following a connection at RESI SF. In January of this year, RESI SF’s partnering system was booked to capacity, with early stage companies and investors – 1200 attendees in total – connecting all day both in scheduled and ad hoc meetings.
LSN will be launching the 2020 RESI calendar with RESI SF on January 14th at the Marine’s Memorial Club and Hotel. For the last two years, RESI SF registration has closed early due to selling to capacity – we recommend registering early to reserve your spot for this event!
RESI back to Europe on March 23rd, 2020 at Hyatt Regency Paris Etoile in France
RESI is returning to the Old Continent for the 2nd RESI Europe conference, this time to be held at the Hyatt Regency Etoile in Paris on March 23rd, 2020. Mark your calendar because you will not want to miss this unique gathering of 200+ global early stage life science investors.
Grants, Seed, Angel, Series A, Series B
The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.
LSN invites tech hubs, entrepreneurs, investors, strategic partners, and service providers to the RESI Conference.